Collaboration supports early detection of pancreatic cancer

Molecular diagnostics startup Abcodia is collaborating with Oxford Gene Technology to discover and validate biomarkers for early detection of pancreatic cancer. Abcodia has a serum biobank including samples from people with pancreatic cancer from up to 7 years before diagnosis, and will use data mining to select sets of samples. Oxford Gene Technology will then screen these samples using its functional protein array platform and Genefficiency microRNA profiling array to identify biomarkers specific to pancreatic cancer. Release

Suggested Articles

The randomized, blinded study showed statistically significant improvements in assessments of inattention and brain activity.

U.K.-based surgery robot developer CMR Surgical has begun rolling out its Versius platform to the NHS, completing its first procedures in Europe.

The former Fierce 15 winner’s SuperMap program was cleared to guide electrophysiologists in the treatment of stable and transient arrhythmias.